An HIV feedback resistor: Auto-regulatory circuit deactivator and noise buffer

PLoS Biology

Volumn 5, Issue 1, 2007, Pages 0067-0081

  Weinberger, Leor S ^a   Shenk, Thomas ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; REPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTEGRATED CIRCUIT; NOISE; OLIGOMERIZATION; STOCHASTIC MODEL; TRANSACTIVATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; GENETICS; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

FEEDBACK, BIOCHEMICAL; HIV; HOMEOSTASIS; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); VIRUS ACTIVATION; VIRUS LATENCY;

EID: 33846360341     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0050009     Document Type: Article

References (70)

1. Samoilov M, Plyasunov S, Arkin AP (2005) Stochastic amplification and signaling in enzymatic futile cycles through noise-induced bistability with oscillations. Proc Natl Acad Sci U S A 102: 2310-2315.
2. Ptashne M (2004) A genetic switch: Phage lambda revisited. Cold Spring Harbor (NewYork): Cold Spring Harbor Laboratory Press. 154 pp.
3. Dodd IB, Perkins AJ, Tsemitsidis D, Egan JB (2001) Octamerization of lambda CI repressor is needed for effective repression of P(RM) and efficient switching from lysogeny. Genes Dev 15: 3013-3022.
4. Hasty J, Pradines J, Dolnik M, Collins JJ (2000) Noise-based switches and amplifiers for gene expression. Proc Natl Acad Sci U S A 97: 2075-2080.
5. Brandman O, Ferrell JE Jr., Li R, Meyer T (2005) Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science 310: 496-498.
6. Ragoczy T, Miller G (2001) Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol 75: 5240-5251.
7. Sarisky RT, Gao Z, Lieberman PM, Fixman ED, Hayward GS, et al. (1996) A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. J Virol 70: 8340-8347.
8. Ragoczy T, Heston L, Miller G (1998) The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72: 7978-7984.
9. Cai W, Astor TL, Liptak LM, Cho C, Coen DM, et al. (1993) The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol 67: 7501-7512.
10. Roizman B, Gu H, Mandel G (2005) The first 30 minutes in the life of a virus: unREST in the nucleus. Cell Cycle 4: 1019-1021.
11. Kent JR, Kang W, Miller CG, Fraser NW (2003) Herpes simplex virus latency-associated transcript gene function. J Neurovirol 9: 285-290.
12. Marchini A, Liu H, Zhu H (2001) Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75: 1870-1878.
13. Heider JA, Bresnahan WA, Shenk TE (2002) Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc Natl Acad Sci U S A 99: 3141-3146.
14. Malone CL, Vesole DH, Stinski MF (1990) Transactivation of a human cytomegalovirus early promoter by gene products from the immediateearly gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins. J Virol 64: 1498-1506.
15. Cherrington JM, Mocarski ES (1989) Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol 63: 1435-1440.
16. Cherrington JM, Khoury EL, Mocarski ES (1991) Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol 65: 887-896.
17. Liu B, Hermiston TW, Stinski MF (1991) A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J Virol 65: 897-903.
18. Garriga J, Bhattacharya S, Calbo J, Marshall RM, Truongcao M, et al. (2003) CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol 23: 5165-5173.
19. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q (2000) Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 275: 279-287.
20. Rusche LN, Kirchmaier AL, Rine J (2003) The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae. Annu Rev Biochem 72: 481-516.
21. Thiel G, Lietz M, Hohl M (2004) How mammalian transcriptional repressors work. Eur J Biochem 271: 2855-2862.
22. Kass SU, Landsberger N, Wolffe AP (1997) DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol 7: 157-165.
23. Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano RF (2004) The multifactorial nature of HIV-1 latency. Trends Mol Med 10: 525-531.
24. Mahmoudi T, Parra M, Vries RG, Kauder SE, Verrijzer CP, et al. (2006) The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 281: 19960-19968.
25. Ott M, Dorr A, Hetzer-Egger C, Kaehlcke K, Schnolzer M, et al. (2004) Tat acetylation: A regulatory switch between early and late phases in HIV transcription elongation. Novartis Found Symp 259: 182-193.
26. Cullen BR (2003) Nuclear mRNA export: insights from virology. Trends Biochem Sci 28: 419-424.
27. Jordan A, Bisgrove D, Verdin E (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. Embo J 22: 1868-1877.
28. Laspia MF, Rice AP, Mathews MB (1989) HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283-292.
29. Frankel AD, Bredt DS, Pabo CO (1988) Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70-73.
30. Kittiworakarn J, Lecoq A, Moine G, Thai R, Lajeunesse E, et al. (2006) HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers. J Biol Chem 281: 3105-3115.
31. Rice AP, Chan F (1991) Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells. Virology 185: 451-454.
32. Stauber RH, Pavlakis GN (1998) Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252: 126-136.
33. Tosi G, Meazza R, De Lerma Barbaro A, D'Agostino A, Mazza S, et al. (2000) Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR. Eur J Immunol 30: 1120-1126.
34. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV (2005) Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122: 169-182.
35. Nevels M, Brune W, Shenk T (2004) SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78: 7803-7812.
36. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16: 1977-1989.
37. Kaehlcke K, Dorr A, Hetzer-Egger C, Kiermer V, Henklein P, et al. (2003) Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell 12: 167-176.
38. Davido DJ, von Zagorski WF, Lane WS, Schaffer PA (2005) Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79: 1232-1243.
39. Mittler JE, Sulzer B, Neumann AU, Perelson AS (1998) Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math Biosci 152: 143-163.
40. Boutell C, Canning M, Orr A, Everett RD (2005) Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J Virol 79: 12342-12354.
41. Bres V, Kiernan RE, Linares LK, Chable-Bessia C, Plechakova O, et al. (2003) A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol 5: 754-761.
42. Jordan A, Defechereux P, Verdin E (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. Embo J 20: 1726-1738.
43. Richter S, Ping YH, Rana TM (2002) TAR RNA loop: A scaffold for the assembly of a regulatory switch in HIV replication. Proc Natl Acad Sci U S A 99: 7928-7933.
44. Karn J (2000) Tat, a novel regulator of HIV transcription and latency. In: Kuiken C, McCutchan F, Foley B, editors. HIV sequence compendium 2000. Los Alamos, (New Mexico): Theoretical biology and biophysics group, Los Alamos National Laboratory. pp. 2-18.
45. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, et al. (2006) NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. Embo J 25: 139-149.
46. Strogatz SH (1994) Nonlinear dynamics and chaos. Cambridge (Massasachusetts): Westview Press. 498 p.
47. Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, et al. (1999) HIV-1 tat transcriptional activity is regulated by acetylation. Embo J 18: 6106-6118.
48. Tramier M, Piolot T, Gautier I, Mignotte V, Coppey J, et al. (2003) Homo-FRET versus hetero-FRET to probe homodimers in living cells. Methods Enzymol 360: 580-597.
49. Volkmer A, Subramaniam V, Birch DJ, Jovin TM (2000) One- and two-photon excited fluorescence lifetimes and anisotropy decays of green fluorescent proteins. Biophys J 78: 1589-1598.
50. Pagans S, Pedal A, North BJ, Kaehlcke K, Marshall BL, et al. (2005) SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 3: e41. doi:10.1371/journal.pbio.0030041.
51. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
52. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
53. Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, et al. (2000) Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277: 278-295.
54. Fall CP (2002) Computational cell biology. New York: Springer. 468 pp.
55. Gillespie DT (1977) Exact stochastic simulation of coupled Ccemical-reactions. J Phys Chem 81: 2340-2361.
56. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
57. Liao W, Tang Y, Kuo YL, Liu BY, Xu CJ, et al. (2003) Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J Virol 77: 9399-9411.
58. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, et al. (2005) Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123: 581-592.
59. Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, et al. (2005) Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123: 593-605.
60. Goldbeter A, Koshland DE Jr. (1981) An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci U S A 78: 6840-6844.
61. Murray JD (2002) Mathematical biology II. New York: Springer. 736 pp.
62. Kuang Y (1993) Delay differential equations: With applications in population dynamics. Boston: Academic Press. 398 pp.
63. Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF (2006) Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog 2: e68. doi:10.1371/journal.ppat.0020068.
64. Lassen KG, Bailey JR, Siliciano RF (2004) Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. J Virol 78: 9105-9114.
65. Ramratnam B, Ribeiro R, He T, Chung C, Simon V, et al. (2004) Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J Acquir Immune Defic Syndr 35: 33-37.
66. Ramratnam B, Mittler JE, Zhang L, Boden D, Hurley A, et al. (2000) The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 6: 82-85.
67. Olaharski AJ, Rine J, Marshall BL, Babiarz J, Zhang L, et al. (2005) The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases. PLoS Genet 1: e77. doi:10.1371/journal.pgen.0010077.
68. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
69. Vaknin A, Berg HC (2006) Osmotic stress mechanically perturbs chemoreceptors in Escherichia coli. Proc Natl Acad Sci U S A 103: 592-596.
70. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298: 1241-1245.